Survey of glargine use in 115 pregnant women with Type 1 diabetes

Diabetic Medicine

Volumn 25, Issue 2, 2008, Pages 165-169

  Gallen, I W ^a   Jaap, A ^b   Roland, J M ^c   Chirayath, H H ^a  

^a WYCOMBE HOSPITAL   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Glargine; Insulin; Pregnancy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO;

ADULT; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG SUBSTITUTION; FEEDING DISORDER; FEMALE; HEALTH SURVEY; HUMAN; HYPERBILIRUBINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN INFUSION; LASER COAGULATION; LIVE BIRTH; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN DEATH; NEWBORN DISEASE; PERINATAL MORBIDITY; PERINATAL MORTALITY; POLYCYTHEMIA; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; SPONTANEOUS ABORTION; TACHYPNEA; THIRD TRIMESTER PREGNANCY; UNITED KINGDOM;

ABORTION, SPONTANEOUS; ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 39749197453     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02339.x     Document Type: Article

References (21)

1. Luzio SD, Beck P, Owens DR. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes Horm Metab Res 2003 35 : 434 438.
2. Gerich J, Becker RH, Zhu R, Bolli GB. Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine. Diabetes Technol Ther 2006 8 : 237 243.
3. Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000 49 : 999 1005.
4. Bolli GB, Owens DR. Insulin glargine. Lancet 2000 356 : 443 445.
5. Di Cianni G, Volpe L, Lencioni C, Chatzianagnostou K, Cuccuru I, Ghio A et al. Use of insulin glargine during the first weeks of pregnancy in five type 1 diabetic women. Diabetes Care 2005 28 : 982 983.
6. Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K. Use of insulin glargine during pregnancy in seven type 1 diabetic women. Diabetes Care 2005 28 : 2594 2595.
7. Torlone E, Gennarini A, Ricci NB, Bolli GB. Successful use of insulin glargine during entire pregnancy until delivery in six Type 1 diabetic women. Eur J Obstet Gynecol Reprod Biol. 2007 132 : 238 239.
8. Larsen J. Efficacy and Safety of Insulin Detemir Versus NPH Insulin in Pregnant Women With Type 1 Diabetes. 2007. Available at http://www. clinicaltrials.gov/ct/show/NCT00474045?order=7 Last accessed 3 September 2007.
9. Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Toxicol 2002 21 : 181 189.
10. Devlin JT, Hothersall L, Wilkis JL. Use of insulin glargine during pregnancy in a type 1 diabetic woman Diabetes Care 2002 25 : 1095 1096.
11. Caronna S, Cioni F, Dall'Aglio E, Arsenio L. Pregnancy and the long-acting insulin analogue: a case study. Acta Biomed 2006 77 : 24 26.
12. Graves DE, White JC, Kirk JK. The use of insulin glargine with gestational diabetes mellitus. Diabetes Care 2006 29 : 471 472.
13. Price N, Bartlett C, Gillmer M. Use of insulin glargine during pregnancy: a case-control pilot study BJOG 2007 114 : 453 457.
14. Holstein A, Plaschke A, Egberts EH. Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes. Diabet Med 2003 20 : 779 780.
15. Hanson U, Hagenfeldt L, Hagenfeldt K. Glycosylated hemoglobins in normal pregnancy: sequential changes and relation to birth weight. Obstet Gynecol 1983 62 : 741 744.
16. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004 328 : 915 917.
17. Yki-Jarvinen H, Dressler A, Ziemen M, HOE 901/3002 Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. Diabetes Care 2000 23 : 1130 1136.
18. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997 315 : 275 278.
19. Penney GC, Mair G, Pearson DW, Scottish Diabetes in Pregnancy Group. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG 2003 110 : 315 318.
20. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004 27 : 2819 2823.
21. Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 2006 333 : 177 182.